Jean‐Pierre Girma

Specific von Willebrand factor–cleaving protease in thrombotic microangiopathies: a study of 111 cases

Agnès Veyradier, Bernadette Obert, Anne Houllier et al. · Blood · 2001 · 383 citations · Full text

Medicine, Hematology, Pathology +14

Prognostic value of anti-ADAMTS13 antibody features (Ig isotype, titer, and inhibitory effect) in a cohort of 35 adult French patients undergoing a first episode of thrombotic microangiopathy with undetectable ADAMTS13 activity

Silvia Ferrari, Friedrich Scheiflinger, Manfred Rieger et al. · Blood · 2006 · 294 citations · Full text

Medicine, Hematology, Internal Medicine +7

Pseudo-von Willebrand's Disease

Harvey J. Weiss, Dominique Meyer, Rosanne Rabinowitz et al. · New England Journal of Medicine · 1982 · 227 citations

Medicine, Hematology, Pathology +17

von Willebrand Factor: Structure and Function

Dominique Meyer, Jean‐Pierre Girma · Thrombosis and Haemostasis · 1993 · 181 citations

Life Sciences, Molecular Biology, Structural Biology +7

Severe deficiency of the specific von Willebrand factor-cleaving protease (ADAMTS 13) activity in a subgroup of children with atypical hemolytic uremic syndrome

Agnès Veyradier, Bernadette Obert, Élie Haddad et al. · The Journal of Pediatrics · 2003 · 97 citations

Medicine, Hematology, Pediatrics +16